title: New Delhi metallo-beta-lactamase from traveler returning to Canada.
abstract: An Escherichia coli isolate with New Delhi metallo-beta-lactamase was isolated from a patient with pyelonephritis and prostatitis who returned to Canada after recent hospitalization in India. The patient was successfully treated with ertapenem and fosfomycin. This patient highlights the role of international travel in the spread of antimicrobial drug resistance and blaNDM-1.
authors.affiliation: Calgary Laboratory Services, Calgary, Alberta, Canada.
authors.forename: Gisele
authors.initials: G
authors.lastname: Peirano
authors.forename: Jasmine
authors.initials: J
authors.lastname: Ahmed-Bentley
authors.forename: Neil
authors.initials: N
authors.lastname: Woodford
authors.forename: Johann D
authors.initials: JD
authors.lastname: Pitout
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D002170:Canada; D015780:Carbapenems / Q000494:pharmacology; D024901:Drug Resistance, Multiple, Bacterial; D000077727:Ertapenem; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000382:microbiology*; D005578:Fosfomycin / Q000627:therapeutic use; D006801:Humans; D007194:India; D008297:Male; D008826:Microbial Sensitivity Tests; D011472:Prostatitis / Q000382:microbiology*; D011704:Pyelonephritis / Q000382:microbiology*; D014195:Travel; D014556:Urine / Q000382:microbiology; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism*; D047090:beta-Lactams / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D047090:beta-Lactams; D005578:Fosfomycin; D001618:beta-Lactamases; C552864:beta-lactamase NDM-1; D000077727:Ertapenem